Drug Shortage Report for MYLAN-BACLOFEN

Last updated on 2023-08-16 History
Report ID 189891
Drug Identification Number 02088401
Brand name MYLAN-BACLOFEN
Common or Proper name BACLOFEN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BACLOFEN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-07
Estimated end date 2023-08-03
Actual end date 2023-08-04
Shortage status Resolved
Updated date 2023-08-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2023-08-16 French Compare
v21 2023-08-16 English Compare
v20 2023-08-01 French Compare
v19 2023-08-01 English Compare
v18 2023-07-18 French Compare
v17 2023-07-18 English Compare
v16 2023-06-21 French Compare
v15 2023-06-21 English Compare
v14 2023-06-13 French Compare
v13 2023-06-13 English Compare
v12 2023-05-31 French Compare
v11 2023-05-31 English Compare
v10 2023-05-23 French Compare
v9 2023-05-23 English Compare
v8 2023-05-16 French Compare
v7 2023-05-16 English Compare
v6 2023-05-08 French Compare
v5 2023-05-08 English Compare
v4 2023-05-01 French Compare
v3 2023-05-01 English Compare

Showing 1 to 20 of 22